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A promising new therapeutic modality for skin can-
cer, administration of the heme precursor 5-aminole-
vulinic acid followed by light irradiation, is known as 
photodynamic therapy. Photofrin, the only clinically 
approved sensitizer, has an absorption maximum at 
630 nm, the wavelength used in most experimental 
and clinical trials with 5-aminolevulinic acid. We 
investigated photodynamic efficacy of irradiation 
with coherent light at wavelengths ranging from 622 
to 649 nm in vitl'o and in vivo as well as the content and 
distribution of intracellular porphyrin after adminis-
tration of 5-aminolevulinic acid. 
HaCaT immortalized human keratinocytes were 
sensitized with 30 ~-tg/ml 5-aminolevulinic acid for 
24 h in vitl'o. By cell viability determined with the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide assay, the best cell-killing effects were 
observed after irradiation at 635 nm. Using an amela-
0 ver the last decade photod ynamic therapy (PDT) has shown e ffi cacy in th e curativ e and paLliative t reatm e n t of cancer and premalig nan t conditions [1-3] . PDT works by activa tion of photosensitiz-in g m o lecul es through light irradiatio n, w hich in 
turn generates reactive oxygen species and damages tumor ce lls and 
tumor microvasculature (for review sec [1 ,4]) . 
Of partic ular interest in de rmatology is topical appli cation of 
photosensitizers such as 5-aminolevulinic acid (5-ALA) . 5- ALA, a 
precursor of the biosynthe ti c p athway of he m e, is m eta bo li zed in 
tissue to porphyrins [2,5]. Hype rpro li fe rative tissues tend to accu-
mul ate more po rphyrins [2,6] and show a characte ristic red fluo-
rescence or phototoxic dam age when exposed to activating light 
[7-9]. T hese efFects have been used in the diagnosis and treatment 
of basa l ce ll ca rcin o mas, squamou s ce ll ca rcinomas, actinic ke rato-
ses, and c utaneous m e tastases of breast ca rcin oma [2, 10,1 1] . The 
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notic melanoma (A-Mel-3) grown subcutaneously in 
Syrian Golden hamsters, we confirmed these results 
ill vivo: tumor growth was markedly delayed in ani-
mals treated with 100 mg/kg 5-aminolevulinic acid 
intravenously and irradiated with coherent light at 
635 nm as compared to animals irradiated at 630 nm. 
This photodynamic effect is probably mediated by 
large amounts of the photosensitizing porphyrin, 
protoporphyrin IX, localized in cell membranes as 
visualized by confocal laser scan microscopy and as 
determined by high pressure liquid chromatography 
in vitm. The results suggest that irradiation at 635 nm 
with a coherent light source is more effective than 
irradiation at 630 nm for photodynamic therapy with 
5-aminolevulinic acid. Key JVOI'ds: dye lasel'lpol'phJil-illsl 
photodyuamic thempylskiu ca.11ce1'. J bwest Del'ma.tol 105: 
672-677, 1995 
best results have been repo r ted for superficial les io ns, because 
5-ALA pene tratio n seems to be limi ted to areas w ith abnormal 
kera tin constitution in the horny layer [2]. Moreove r, accumulation 
of po rphyrins fo llow ing topica l 5-ALA application is pro bably 
restt·icted to epide rmis and skin appe ndages [2,7,12] . However, 
systemica lly adm iniste re d 5- ALA localizes in liver, skin, bone 
marrow , and other pathologic and normal tissues that contain 
pro li ferating cells that synthes ize heme and porphyrins [2]. 
Due to the fact that PDT with the hematoporphyrin d erivative 
Photofrin, the o nly clinically approved sensitizer, is performed by 
irradiation at 630 nm when a coherent light source is used [13 ,14], 
m ost investigatio ns i11 11itro and i11 11ivo use the same wavelength w ith 
5-ALA-induced porphyrins [1 0,15]. Howeve r, using a wavelength 
not associated with maximum absorptio n could result in a differen t 
and poss ibly less successful therapeutic o u tcome [11 ,16] . There-
fore, w e determined the optimum wavelength for irradiation with 
coherent ligh t after 5-ALA-induced porphyrin sensitization in both 
i11 vitro and i11 11ivo expe rim ental settings. 
MATEIUALS AND METHODS 
Cell Culture Human immorta li zed keratinocyte cell lines (1-laCaT [1 7]) 
were rn aintaincd under standard conditi o ns and were p lated in 96-wcll 
plates (7 X 104 ce lls per dish). Medium was removed after 16 h, serum-free 
medium (1 00 JLl) , containing 5-ALA (30 JLg/ mJ, Merck AG, Darmstadt. 
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Germany) was added, and cells were allowed to take up 5- ALA for 24 h . 
Medium containing 5-ALA was removed, and cell s were rinsed once with 
phosphate-buffered saline (PBS) and then submerged in PBS. Irradiation 
was perfom1ed immediately afterwards. 
Irradia tion Procedure Irradiation for cell cul ture and for animal studies 
was performed with an argon-pumped tunable dye laser (models 2040 and 
375, Spectra Physics Lasers Inc., Mountain View, CA) exciting Kiton red 
dye and producing up to 3.5 W of coherent red light at 630 nm. For 
cell-culture studies, the laser was tuned and single wavelengths between 622 
and 649 1m1 in steps of 3 run were chosen. Wavelengths were con-
trolled by means of a monochromator (Oriel 7240, Oriel, Stamford, Connect-
icut, resolution ::': 1.0 nm) . For the ;, rli11o anim al smdies, 630 and 635 nm 
was used . 
For cell-culture studies, 24 groups were formed (n = 26 for each group). 
The first served as a control and received neither sensitizer nor irradiation. 
The second group was treated with 5-ALA exclusively. Groups 3-13 
received irradiation only at appropriate wavelengths , and groups 14-24 
were sensitized w ith 5-ALA and irradiated (40 mW /cm2 , 30 j/cm2 ) as 
described previously [1 8]. 
Cell Survival as Determined with the MTT Test After PDT, an 
MTT [3- ( 4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide J as-
say was performed immediately to check cell viability (described in [19,20]) . 
Briefly, cells were washed once aga.in with PBS, and 25 J.Ll of5 mg/ml MTT 
dissolved in PBS was added. MTT was removed after 2 h , and 100 J.Ll of a 
20% sodium dodecylsulfate solu tion was added for complete dissolution of 
the formazan dye . Optical density of wells was read with an enzyme-linked 
immunosorbent assay reader at 540 nm. Absorbance of the solution from 
the treated groups was divided by absorbance of the solution from the 
controls to calcul ate the survival fraction. 
Analysis of Porphyrins with High-Pressure Liquid Chromatogra-
phy (HPLC) Monolayer cultures (n = 6) of HaCaT cells (3-15 X 1 06 
cells) were incubated w ith 5- ALA at 30 j.Lg/ ml fo r 24 h (conditions as 
described above , but with 10% feta l bovine serum instead of serum-free 
medium). After incubation, supernata nts were separated, and porphyrins 
were extracted with a mixture of 1 N perchloric acid/ methanol 1:1. 
Porphyrin accumulation was analyzed spectrofluorometrically (Spectropho-
tometer C3, Beckman Instruments, Munich , Germany) and expressed as 
nrnol per 1 O'' cell s. Tota l porphyrin content was defmed as the sum of 
porphyrins in cells and corresponding supernatants. Porphyrin metabolites 
were esterified and determined by HPLC (Millipore Waters, Eschborn, 
Germany) . Metabolites were identifi ed accord ing to porphyrin standards 
(Porphyrin standard , Porphyrin Products Inc ., Logan, UT) and quantities 
were expressed as percentage of total porphyrin content [21]. 
Intracellular Localization of Porphyrin F luorescence In tracell ular 
localization of porphyrins was analyzed in cultu red HaCaT cells by means 
of confocal laser scanning microscopy (LEI CA LasertecluUk, H eidelberg, 
Germany). Cell s were cu ltured on microscope slides (n = 5) (Heraeus 
Biotechnology, Hanau, Germany). Fluorescence was excited with a 25-mW 
argon ion laser operating in the vis ible multiline mode (emitted radiation 
was registered at wavelengths more than 610 nm). Fluorescence micro-
graphs we re obtained by means of a high-sensitivity photomultiplier tube 
with identical instrument settings. 
Anhnal Experintents To eva lua te w;welength-dependent photody-
namic effects of 5-ALA iu vi11o , amclanotic melanomas [22] were implanted 
subcutaneously (injection of approximately 5 X 106 A-Mel-3-cells) in the 
dorsal skin of 30 hamsters [23]. Afi:er 5 d tumors with a volum e of approx-
imately 140 mm3 had developed. Pcm1a11ent indwelling catheters (PE 10, inner 
diameter 0.28 mm) were implanted into the right j ugular vein 24 h prior to 
intraveno us injection of5-ALA (100 mg/kg body weight, dissolved in PBS, 
100 mg/ml, pH 6.5). D uring implantation and injection of the photosensi-
tizer and PDT, animals were anesthetized with pentobarbital intraperitone-
ally (60 mg/kg body we ight) . 
To avoid unnecessary animal experiments, iu 11itm data were acquired 
firs t , and for iu vi11o experiments on ly the two wavelengths of interest, 630 
and 635 nm, were used. Five groups of six animals each were studied. 
G roup A served as control and received no treatment. Groups B and C were 
irradiated either at 630 or at 635 nm but received no 5-ALA . Group D 
received 5-ALA and irradiation at 630 nm, and group E received 5-ALA and 
irradiation at 635 nm. 
Laser irradiation was performed 120 min after injection, at the time of 
highest porphyrin concentration in neoplastic tissue as indica ted by intravital 
fluorescence kinetics [16] . For treatment, animals bearing a solid subcuta-
neous tumor were anesthetized and placed in a perspex tube, and a skin fold 
with the tumor was raised through a sli t and fixed in place. The tumor area 
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Table I. Wavelength-Dependent Lowering of Cell 
Viabilities After Photodynamic Therapy with 
5-ALA-Induced Porphyrins" 
No Sensitization Sensitization 
Wavelength [nm] with 5-ALA w ith 5- ALA 
No irradiation 100.0 92. 1 ::': 2.01' 
622 104. 1 ::': 3.0 57.0 ::': 3.7 
625 93.9 ::': 2.9 42.5 ::': 4.3 
628 101.0 ::': 3.6 37.1 ::': 6.0 
631 100.0 ::': 2.5 22.2 ::': 3 .7 
634 90.0 ::': 2.4 13.9 ::': 2.0 
635 80.6 ::': 3 .0 10.8 ::': 0.7 
637 80.7 ::': 3 .8 14.9 ::': 1.2 
640 83.1 ::': 2.9 31.1 ::': 3.5 
643 87.3 ::': 3.8 74.5 ± 5.8 
646 105.4 ::': 3.8 82.6 ::': 5.0 
649 108.5 ::': 2.5 79.9 ::': 5.4 
1
' Photodyna mic therapy in HaCaT kcratinocytcs treated with 5-ALA for 24 h and 
irradiated at diffe rent wavelengths in steps of3 mn using a tunable argon-pumped dye 
lase r (irradiancc 40 mW /cm 2 , light dose 30 j /cm 2) . 
1
' Values given are the mean ± SEM. 
was treated with a laser light intensity of 1 00 m W I cm 2 and a total light dose 
of 100 j/cm2 [24]. 
The longer (/) and shorter (w) perpendicular axes and the height (h) of 
each tumor were measured with calipers prior to and after PDT at 2- 3-d 
in tervals over 28 d. Individua l tumor volume was calculated with the 
formula C X I X 111 X h. where C is 0.873, a correction factor that has been 
determined empirica lly [23,25]. Tumor response to PDT was classified as 
follows: complete remission (disappearance of all signs of tumor), partial 
remission (more than 50% decrease of the product of the two largest 
perpendicular tu mor diameters for a minimum of7 d) , no change (less than 
50% decrease or less than 25% increase of the product of the two largest 
perpendicular tumor diameters fo r a minimum of5 d) , or progression (more 
than 25% increase of the product of the two largest perpendicular diameters) 
[26]. 
Statistics The StatView data analysis system (Abacus Concepts Inc., 
Berkeley, CA) was used fo r statistica l analysis. Results are expressed as 
n1can or n1cdian and SEM. Para1nctric tests were used for the iu 11itm results 
and non-parametric tests were used for the ill 11ivo data. Probability values 
smaller than 5'V., were considered significant. 
RESULTS 
Lowest Cell Viability in HaCaT Keratinocytes After Irradi-
ation at 635 nm HaCaT cell s that received n e ither 5-ALA nor 
irradiation were more th an 95% v iable and served as controls 
(expressed as 100% compared to all other groups) . Cells incubated 
w ith 5-ALA alone did not diffe r significantly (viability 92.1 ::!:: 
2.0%) . As compare d to controls, irradiated cells revealed signifi-
cantly lower viabili ty after irradiation at wavelengths of 635, 637, 
640, and 643 nn1 (p < 0.01) only (Table I). Cell v iability was 
further reduced significantly in all groups trea ted with 5- ALA and 
irradiated at different wave len gth s (groups 14-24) compared to th e 
control group (p < 0 .001) and to all groups treated o nly with 
irradiation (3-13) (p < 0.01) (Fig 1) . T h e minimum cell viability 
was achieved by incubation with 5-ALA and irradiation at 635 nm 
[group irradiated at 631 nm (p < 0.05) or shorter wavelength s (p < 
0 .0001) or at 640 nm or lo nger wavelengths (p < 0.0001)] (Fi g 1). 
Protoporphyrin IX Is Preferentially Synthesized in 5-ALA-
Sensitized HaCaT Cells In untreated cells, only small amounts 
of porphyrins could be found in the monolaye rs ofHaCaT cell s and 
in the corresp o nding supernatants. T h e amount of porphyrin was 
significantly increased in the cells and supernatants 24 h after 
addit io n of 5- ALA; total porphyrin concen tration ranged from 2 .2 
to 3.1 nmol/106 cells, w ith approxim ate ly 70-80% in the super-
natants. Although protoporphyrin IX (PP) (100 ::!:: 0%) was th e only 
p orphyrin metabolite d e tec ted in th e cell s, additional porphyrin 
m e tabolites including copra- (5.5 ::!:: 0.9%) , penta- (8 .3 ::!:: 1.2%) , 
hepta- (1.3 ::!:: 0.5%) , uro- (13.4 ::!:: 1.6%), and protoporphyrin IX 
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Figure 1. Lowest cell viability of HaC aT keratinocytes after PDT 
at 635 nm. HaCaT keratinocytes, 7 X 104 , were seeded in 96-well plates, 
and incubated overnight as described in Materi als mtd M ethods. Afte r removal 
o f medium , cells were treated w ith 5- ALA (30 p,g/ml) disso lved in 
serum-free medium for 24 h. Contro l groups did no t receive 5- ALA . Cells 
were then irradiated with an argon-pumped dye laser at difFe rent wave-
lengths (range 622- 649 nm in steps o f 3 nm, irrad iance 40 mW/cm 2 , light 
dose 30 j /cm 2 . Cell viabili ty was dete rmined with the M TT assay imme-
diately afterwards. N on- incubated and non-irradiated cells se rved as con-
trols (100°/o, viability) . R.csults represent the mean of n = 26 fo r each gro up, 
:!:: SEM. 
(7 1.4 ± 3.4%)· w e re fo und in corresp o nding supe rn atants b y the 
HPLC sys te m (Fig 2) . 
Protoporphyrin IX I s Membrane Bound in 5-ALA-Sensi-
tized HaCaT Cells Using confocal mic roscopy , w e did not 
d etect fluorescen ce in cell s prio r to inc uba tion with 5-ALA (con-
trols) . In H aCaT cell s incubate d fo r 2 4 h with 5- ALA , str o n g 
fluorescen ce w as d e tectable in cell m e mbranes , but nucle i, nuclear 
m e mbran es, mitoch o ndria , and c ytoplasm sho w e d n o flu o rescence 
(Fig 3A,B). 
0 
Proto Copra Penta Hexa Hepta Uro 
Figure 2. Protoporphyrin IX is the preferentially synthesized por-
phyrin after exogeneous 5-ALA administration in HaCaT kerati-
nocy tes. H aCaT cell s, 3-1 5 X 1 O", were incubated with 30 p,g/ml 5-A LA 
fo r 24 h . Supernatants were then separated and po rph yrins were ex tracted 
with a 1 :1 mixture of 1 N perchloric acid:methano l. Po rph yrin metabolites 
we re este ri fied and dete rmined by HPLC. Percentage of po rph yrin metab-
oli te concentration of to tal porphyrin content (determined spectroAuoro-
metrica ll y) were calculated both in HaCaT cells and corresponding super-
natants (mean :!:: SEM). T he black columns rep resent the HaCaT ce ll s, the 
white columns the supermltants. 
T H E JOUilNAL OF INVESTIGATI VE DEilMATOLOCY 
Figure 3. Protoporphyrin IX is present in plasma membranes after 
5-ALA sensitization. H aCaT ce ll s were cultured on glass slides and were 
incubated w ith 5-ALA (30 JLg/ml) fo r 24 h. Investigation with confoca l 
laser scanning n1icroscopy (A uo rcsccncc excita tio n \.Y ith an argon laser. 
emitted radiation detection above 6 '1 0 nm) showed membrane bound 
flu o rescence of PP {A); weak or absen t flu o rescence was o bserved in 
cytoplasmic and nuclear structures . Phasl!-con trast microbrraph for com par-
ison (B) (scale bars, 1 0 JLm) . 
Wavelength-Dependent Tumor Growth Delay Five d ays 
afte r implanta tion , the tumo rs h ad g rown to di am e ters o f abo ut 5 
mm (mean tumo r volume, 139 ± 9.5 mm3 ) . T h e re were n o 
sta ti sti ca l diffe re n ces b e tween tumo r volum es of any of th e exper-
im e nta l g roups (A-E) b e fo re photod ynami c th e rap y . 
Nine d ays after treatme nt , average tumo r volum e o f th e PDT 
g ro up irradi a te d at 635 nm (group E) was 98'!/o, lower (39 ± 390 
cm
3 ) (median ± SEM ) than in g ro up A ( 1. 631 ± 253 cm 3 , p < 
0 .0 5) , 98% lowe r than in g roup B (2 138 ± 3 18 cm 3 , p < 0.05) , and 
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Figure 4 . Increased tumor growth delay after 5-ALA-PDT at 635 
nm. A-M el-3 amclan otic m elano mas we re implanted subcutaneously in the 
d orsal skin fo ld of Syri an golden hamste rs (n = 30). Afte r 5 d , tumo r vo lume 
reached approximate ly 140 mm3 Five gro ups we re formed w ith di l!e rcnt 
experimental settings [con tro ls (A), irradi atio n w ith red light at 630 (B) o r 
635 nm (C). 5- ALA (100 1-Lg/ kg body we ight, given intravenously) plus 
ligh t at 630 (D) o r 635 nm (E)], and tumo r volumes we re recorded 
thro ugho ut the complete observation period (28 d) . Median tumo r vo lumes 
were m easured as a fun ctio n of ti me (median em' ::': SEM). 
96% lower than in group C (928 :t 735 cm 3 , p < 0.05) . Differences 
in t umor volum es between g ro up E and group D (1 530 :t 378 cm 3 ) 
irradiated at 630 nm w ere also significant (p < 0.05). Tumo r 
v olume in gro up C w as significantl y lower (57%, p < 0.05) than in 
group B (Fig 4). 
No Marked Diffe rence in Final Therapeutic Outcome Re-
garding Complete Remission All 12 tum ors in the two PDT 
groups (D ,E) fo rmed thick escars by 1 week after PDT trea tmen t 
(Fig SA,B,C). O nly one o f the PDT -treated tumors ill gro up E 
resolved comple te ly (fo llow- up until day 28), but three of six 
animals in gro up E (635 nm irradiation and 5-ALA) showed partial 
remission. Only one tum or in group D (630 nm irradiatio n and 
5-ALA) showed partial remission . T umo r growth in the control 
group (A) and in the gro up irradiated only at 630 nm (B) w as no t 
reduced, wh ereas in gro up C (63 5 nm irradiation o nly) o ne partial 
remission was o bserved (Table II) . H ow eve r, compared to the 
significant tumo r-growth delay, a m arked di ffe rence in th e fi n al 
th e r apeutic o u tcom e afte r 28 d regarding compl ete remission w as 
not o bserved between the differen t gro ups. 
DISCU SS IO N 
This study provides evidence fo r w avelength dependency o f cell 
viabili ty and tumo r response afte r photosensi tization with 5-ALA 
and irradiatio n w ith coherent ligh t. R egardin g Fig 1 , there w as a 
significant decrease in mean cell viabilj ty in H aCaT cells afte r 
F igure 5. Response of amelanotic melanoma (A -Mel-3) in the 
Syrian g olden hamster to PDT with 5-ALA. Syrian golden hamsters 
with subcutaneously implanted A-Mel-3 amelanotic me lano mas wen! 
treated w ith 5- ALA-PDT. Five days after implantation, subcutan eous 
tumors. approx imate ly 140 mm' in vo lume , had developed (A) . T umors 
were then treated wi th 5- ALA given in trave nously (1 00 1-Lg/kg body 
weig ht) and irradia tion w ith an argon- pumped d ye laser (120 min la te r, 
irradiance 100 mW /cm 2 , light dose 100 j /cm 2 • A. = 635 nm). T w enty-fo ur 
hours after treatmen t , ini tial rumo r necrosis occurred (B) . N ine da ys after 
treatm e nt, tun1o r necros is \Vas aln1ost corn plctc , and rnassivc cscar fornta-
tion d eve loped (C). H owever, at tha t ti m e tumor regrow th occurcd alread y 
(an·o w). 
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Table II. No Marked Difference in Therapeutic Outcome Regarding Complete Remission After PDT with 5-ALA at 
635 nm or at 630 nm in Amelanotic Melanoma Bearing Syrian Golden Hatnsters" 
Groups 
A 
B 
c 
I) 
E 
ALA [mg/kg bo d y we ig h t] / 
wave len gth [nm] 
Controls (0 / 0 ) 
0 / 630 
0 /635 
100/630 
100/635 
Complete 
Rem ission 
0/6 
0/6 
0/6 
016 
1/6 
Partial 
Rcrnission N o C h ange Progressio n 
0/6 0/6 6/ 6 
0/6 016 6/6 
•J/6 0/6 5/6 
.I /6 0/6 5/6 
3/6 0/6 2/6 
·' Data represent the therapeutic omcornc <Jf!cr 28 d of a subcut:lll co usly impl;mtcd nmcla notic malignant melanoma (A-Mcl-3) in Syrian golden hamsters fo llowing PDT with 
5-ALA ( 100 mg/kg body weight, given intr:lVcno usly) and irrndiation afte r 120 min using coherent light (argon-pumped tunable dye laser, irradi:m cc 100 m W / cm2 , dose 100 
j/cm2 ) at 630 o r 635 11111 . 
irradi ation at 635 nm as compared to other wavelengths. Even a 
change of about 4 nm in irrad iation wavelength led to significan t 
chan ges in celJular response to 5-ALA-mediated PDT i11 11itro. 
T hese fi nd in gs we re then confirm ed i11 11i11o using the model of the 
amelanotic melanoma growing subcu taneous ly in Syrian golden 
ham sters [22,23 ]. T he change of the irradia tion wave length from 
630 to 635 nm led to a significa n t tumo r g rowth dela y after PDT. 
T hus, it seem s to be im porta n t to choose the optimal wavelength 
for the specifi c sensitize r used. H owever , a marked difi:c rence in the 
fina l therapeutic o utcom e after 28 d rega rding complete remission 
was not o bserved, possibly due to the small number of experim ents. 
Altho ugh most nucl e<lted m amm alian ce ll s require heme and are 
ab le to synthesize it [5], the re arc difrcrcn ces in the po rph yrin 
formation . He and co-workers showed a time-dependent increase 
of porphyrin accumul ation of up to 48 h in a human epiderm al 
carcin oma cell lin e and in normal hum an keratinocytcs [27). 
T he refore, w e used an in cubation time of 24 h for the i11 11itro 
studi es, altho ugh in an i11 11 i11o m odel afte r in traveno us app licatio n of 
100 mg/kg bo.dy weight 5-ALA in gold en hamsters, Auorescence 
kinetics revealed the highest am ounts of endogeneo usly formed 
porphyrins at 120 min [1 6]. 
Pottie r et a/ in vestigated excitation spectra i11 11itro and i11 11i11o in 
mo use ski n after in traperitonea l inj ection of 5- ALA. Flu orescence 
maxima of PP w ere detected at 629 nm i11 vitro and at 632 nm i11 
11i11o, but absorbance ma xima i11 11i11o and i11 11itro were not consid-
e red . Absorbance spectra of PP in dim ethylsulfoxide exhibi t an 
absorbance m aximum at 629.2 nm [8]. Us ing the ir res ults, several 
g rou ps perfo rm ed PDT after 5- A LA sensitiza tion at a wavelength 
of 630 nm [2,1 0, 15]. H owever, Goff and co- wo rke rs a lso noted a 
3-4-mm red shift between excitation and emission spectra of PP 
dissolved in m ethano l and i11 JJ iiJo us ing topi ca l 5-A LA for PP 
form ation in guinea pig skin [28]. Moreover, they demonstrated 
that add itio n of bovin e serum albumin to a PP-methanolic solu tion 
is able to create thi s shi ft and that this effect is probably based on 
protein binding of porph yrins [28]. T herefore, it was like ly that 
sim ilar e frccts would inAu ence absorbance spectra of PP in ce ll 
culture or ti ssue leading to better qu antum yie lds w hen irrad iation 
wavelength was shi fted slightl y furthe r in to the red po rti on of th e 
spectrum as is indi cated in the presen t stud y. 
To sh ow cell -ki lling e ffects of PDT, the MTT test is a va luable, 
well -esta blished method [19]. To demon strate porph yrin form ation 
in cell cu lture and tissue, HPLC analysis is used as an in ternational 
standard [21] , and pro vided qua litati ve and quantitative data on 
formation of d ifrerent po rphyrin s in HaCaT cells and in the ir 
supernatants. Follow ing longer incubati on pe ri ods, othe r porphy-
rin s in addition to PP might be formed and could be responsibl e for 
destru ctive effects of photosensitization . However, even afte r 24 h 
of 5-ALA in cubation the main porphyrin remaining in I-I a CaT ce lls 
is PP, as measured by 1-!PLC . 
T hus cell destru ction seems to be m ediated almost excl usive ly by 
PP. Recentl y, H e et a/ [27] de tected a time-dependent increase of 
PP over 48 h inside normal human kc ratin ocytes in the presence of 
1.0 mM 5- ALA, and iden tified extracted porphyrins using Auores-
cence emission spectra. Like our results, th ei1· analysis showed that 
90 -100% of tota l po rphyrins in the cells and 50-100°/t, of to tal 
po rphyrins in the supernatant is PP [27]. 
T he working hypoth esis fo r cytotox icity of PDT with 5-ALA-
induced PP is mitochondrial phototoxicity, as suggested by l.inum a 
et a/ [2 9]. However , in this study, using confocal lase r scanning 
mi croscopy, w e de tected flu o rescence after 24 h 5-ALA incubation 
onl y in plasm a-m embrane structures of Ha C aT ke ratin ocytcs . T his 
o bservation is in contrast to findings by linuma eta/ , who m easured 
stro ng perinuclear flu orescence, indicating loca liza ti on in mito-
chondri a of epi the lial cell s afte r 4 h of incubation with 1 mM 
5-ALA [29]. T hey did not investigate po rphyrin distribution at later 
times. It is possible that longer in cubation times (24 h) led to 
diWe rent intracellular distribu tion of po rphyrins. Due to its li-
po phili c behav ior, PP shows strong membrane binding [30,31], like 
o the r lipophilic sensiti zers. For example , Artuc et a/ found m assive 
damage of the pl asma m embrane ofhuman epide rmal kera tinocytes 
a fte r PDT w ith hem atoporphyrin, indi cating re lease of the cytosolic 
enzyme lac tate dehydrogenase [32]. Leunig cl a/ dem onstrated 
outer m embra ne damage i11 A-Me l-3 tumor ce lls i11 vitro after PDT 
w ith Photofrin by transmission electron microscopy [33]. T hus, in 
case of PP ove rload in ce ll s after longer in cubation times, PP 
accumulation h as been shown in plasma cell membranes . /11 IJiiJo 
results might dille r due to the sho rte r in cubation time, and porphy-
rins mi ght be synthesized in diffe rent amounts. In terestingly, sig-
nifi ca nt lower ce ll viabi lities were seen also in HaCaT cells not 
in cubated w ith 5-ALA and irradiated at 635-643 nm . T his e frec t 
co uld be due to the presence of physiologic am ounts of PP as 
confirmed w ith HPLC analysis (5,6,34]. 
O ur data indica te that irradiation w ith a co herent light source at 
the wavelength gene rall y used in the clinica l setting , 630 nm , is not 
the wavelength to o btain best the rapeutic res ults. However, in 
tumor-bearing nude mice treated with 5-ALA-PDT, chlorin-type 
photoproducts of protopo rph yrin w ere found it1 IJ iiJO, and these 
ph o toproducts stil l have photosensitiz ing properties at an absorp-
tion m ax imum of 670 nm [1 5,35]. T he refore, it m ay be more 
reasonabl e to choose a light source that cove rs all optimal wave-
leng ths for irradiati on . For exam pl e, in case of surf.<ce irradiati on in 
PDT of dermatolog ic conditions, this co uld be achieved by using an 
incoheren t lamp with a spectrum of irradian ce ranging from 600 to 
750 nm [1 8]. Moreover, because of the broad spectrum of irradi-
ation , a wavelength shift of the absorp tion spectrum of the photo-
sensitizer would not aWect th e the rapeu tic o utcom e [18]. 
T his 111ork wns s11ppor1cd by grn11ts •!I I he BMFT (0 t EK940 1-DLR Bn1111) nud 
lhe OFG (Ln 6201 1- 1-6 18/89) . 1-fnGnT cdls I<'Crc kiudly provided IJ)' Pr<:J{ 1'< . 
Fuscu(~, OKFZ 1-fddt•ll>et~ /Gerlll a ll )'. We lhnuk Dr. R. Bnuru.~mwerforji·uiiful 
dist: tlss ious. 
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